Drug Discovery Services | Lead Compound Identification/Optimization | Charles River

drug discovery 

The path from lead to candidate selection can include many crossroads, where choosing the right science at the right time can determine a program’s ultimate success. Charles River provides drug discovery support in a contract research capacity, with a strategic partner approach. From candidate screening to safety assessment, early drug discovery determinations are supported by our collective expertise across the complete drug development spectrum.

Our staff is well-versed in simple to complex phenotyping and interpretation across all major therapeutic areas. We offer a range of challenge models mimicking human disease, as well as pathophysiological analysis and insights on the transition to the human condition(s). Studies are conducted in a highly controlled environment to minimize variability when phenotyping across lines and to ensure high-quality data that is both robust and reproducible.



Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all
This webinar focuses on quantitative, translatable imaging technologies and their background and application in the area of oncology, highlighting the critical advantages that can be imparted to drug discovery and development by their use.

News & Events

view all
Apr 15 - Putting the 3Rs of Biomedical Rese...
Apr 15 - Charles River Signs Partnership Ag...
Jun 22-Jun 26 - Tucson, AZ - Teratology Society Annual Meeting
May 28-Jun 01 - Kobe, Japan - Joint Meeting of the International Bone and Mineral Socie...
May 23-May 23 - East Lansing, Michigan, USA - The Ins and Outs of Transgenic Colongy Ma...

Charles River Laboratories, Inc.